ABCG2 and cancer: The fatty acid biosynthesis pathway (ko00061) and ABC transporters pathway (ko02010) were more significantly enriched in the treatment II group (Figure 4B), while the glycerophospholipid metabolism (ko00564) and choline metabolism in cancer (ko05231) pathway were greater in the urine of the treatment III group (Figure 4C).